Edwards Up, Medtronic Down After Court Hits CoreValve
Shares of device maker Edwards Lifesciences (EW) jumped 14% in early trading in the stock market today after word got out late Friday that the company had won a court injunction limiting the sale of Medtronic’s (MDT) CoreValve artificial heart valve in the U.S. Medtronic stock was down 3%. CoreValve, which has been sold in Europe for several years, was approved by the FDA in January. But Edwards, whose rival Sapien product has been sold in America